Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: Results of the IASP study

Addiction

Volumn 109, Issue 2, 2014, Pages 262-272

  Van Emmerik van Oortmerssen, Katelijne ^a,b,c   van de Glind, Geurt ^b,d   Koeter, Maarten W J ^b   Allsop, Steve ^e   Auriacombe, Marc ^f   Barta, Csaba ^g   Bu, Eli Torild H ^h   Burren, Yuliya ⁱ   Carpentier, Pieter Jan ^j   Carruthers, Susan ^e   Casas, Miguel ^k   Demetrovics, Zsolt ^l   Dom, Geert ^m   Faraone, Stephen V ⁿ   Fatseas, Melina ^f   Franck, Johan ^o   Johnson, Brian ⁿ   Kapitány Fövény, Máté ^l,p   Kaye, Sharlene ^q   Konstenius, Maija ^o   Levin, Frances R ^r   Moggi, Franz ^i,s   Møller, Merete ^t   Ramos Quiroga, J Antoni ^k   Schillinger, Arild ^t   Skutle, Arvid ^h   Verspreet, Sofie ^m   van den Brink, Wim ^b   Schoevers, Robert A ^c   Beniwal, Atul ^u   Bosma, Geert ^u   Cassar, Joanne ^u   Dahl, Therese ^u   Daigre, Constanza ^u   Debrabant, Romain ^u   Degenhardt, Louisa ^u   van der Gaag, Rutger Jan ^u   Hay, David ^u   Lossius, Kari ^u   Løvaas, Eva Karin ^u   Malivert, Marion ^u   Möller, Merete ^u   Roncero, Carlos ^u   Stevens, Laura ^u   Wallhed, Sara ^u   van Wamel, Anneke ^u   Young, Jesse ^u   more..

^a Arkin Mental Health and Addiction Treatment Centre   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^e CURTIN UNIVERSITY   (Australia)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g SEMMELWEIS UNIVERSITY   (Hungary)

^h Bergen Clinics Foundation   (Norway)

ⁱ UNIVERSITY OF BERN   (Switzerland)

^j Reinier Van Arkel Groep   (Netherlands)

^k HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^l EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^m PC Alexian Brothers   (Belgium)

ⁿ State University of New York Upstate Medical University: College of Medicine   (United States)

^o KAROLINSKA INSTITUTE   (Sweden)

^p Nyiro Gyula Hospital   (Hungary)

^q UNIVERSITY OF NEW SOUTH WALES   (Australia)

^r NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^s UNIVERSITY OF FRIBOURG   (Switzerland)

^t Ostfold Hospital Trust   (Norway)

^u NONE

more..

Author keywords

ADHD; Antisocial personality disorder; Bipolar disorder; Borderline personality disorder; Comorbidity; Depression; Substance use disorder

Indexed keywords

ADOLESCENT; ADULT; AGED; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT ATTITUDE; PERSONALITY DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RISK FACTOR; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PERSONALITY DISORDERS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84892431375     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12370     Document Type: Article

References (49)

1. van Emmerik-van Oortmerssen K., van de Glind G., van den Brink W., Smit F., Crunelle C. L., Swets M. etal. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 2012; 122: 11-19.
2. van de Glind G., Konstenius M., Koeter M. W., van Emmerik-van Oortmerssen K., Carpentier P. J., Kaye S. etal. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend; in press; 2013.
3. Chen K. W., Banducci A. N., Guller L., Macatee R. J., Lavelle A., Daughters S. B. etal. An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program. Drug Alcohol Depend 2011; 118: 92-99.
4. Chan Y. F., Dennis M. L., Funk R. R. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat 2008; 34: 14-24.
5. Bernardi S., Faraone S. V., Cortese S., Kerridge B. T., Pallanti S., Wang S. etal. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med 2012; 42: 875-887.
6. Kessler R. C., Adler L., Barkley R., Biederman J., Conners C. K., Demler O. etal. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006; 163: 716-723.
7. Carpentier P. J., van Gogh M. T., Knapen L. J., Buitelaar J. K., De Jong C. A. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res 2011; 17: 10-20.
8. Kim J. W., Park C. S., Hwang J. W., Shin M. S., Hong K. E., Cho S. C. etal. Clinical and genetic characteristics of Korean male alcoholics with and without attention deficit hyperactivity disorder. Alcohol Alcohol 2006; 41: 407-411.
9. Wilens T. E., Kwon A., Tanguay S., Chase R., Moore H., Faraone S. V. etal. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Am J Addict 2005; 14: 319-327.
10. King V. L., Brooner R. K., Kidorf M. S., Stoller K. B., Mirsky A. F. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis 1999; 187: 487-495.
11. Arias A. J., Gelernter J., Chan G., Weiss R. D., Brady K. T., Farrer L. etal. Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav 2008; 33: 1199-1207.
12. Castells X., Ramos-Quiroga J. A., Rigau D., Bosch R., Nogueira M., Vidal X. etal. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs 2011; 25: 157-169.
13. Tamm L., Adinoff B., Nakonezny P. A., Winhusen T., Riggs P. Attention-deficit/ hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder. Am J Drug Alcohol Abuse 2012; 38: 93-100.
14. Elkins I. J., McGue M., Iacono W. G. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 2007; 64: 1145-1152.
15. Sobanski E., Bruggemann D., Alm B., Kern S., Philipsen A., Schamalzried H. etal. Subtype differences in adults with attentiondeficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry 2008; 23: 142-149.
16. Larsson H., Dilshad R., Lichtenstein P., Barker E. D. Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology. J Child Psychol Psychiatry 2011; 52: 954-963.
17. Friedrichs B., Igl W., Larsson H., Larsson J. O. Coexisting psychiatric problems and stressful life events in adults with symptoms of ADHD-a large Swedish population-based study of twins. J Atten Disord 2012; 16: 13-22.
18. Wilens T. E., Biederman J., Faraone S. V., Martelon M., Westerberg D., Spencer T. J. Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry 2009; 70: 1557-1562.
19. Sprafkin J., Gadow K. D., Weiss M. D., Schneider J., Nolan E. E. Psychiatric comorbidity in ADHD symptom subtypes in clinic and community adults. J Attention Disord 2007; 11: 114-124.
20. ICASA. Website ICASA Foundation. Available at: http://www.adhdandsubstanceabuse.org/. (accessed 26 April 2013) (Archived by WebCite® at http://www.webcitation.org/6GAFo8jIs).
21. van de Glind G., van Emmerik-van Oortmerssen K., Carpentier P. J., Levin F. R., Koeter M. W., Barta C. etal. The International ADHD in Substance use disorders Prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res; in press; 2013.
22. Epstein J. N., Kollins S. H. Psychometric properties of an adult ADHD diagnostic interview. J Attention Disord 2006; 9: 504-514.
23. Sheehan D. V., Lecrubier Y., Sheehan K. H., Amorim P., Janavs J., Weiller E. etal. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33.
24. Williams J. B., Gibbon M., First M. B., Spitzer R. L., Davies M., Borus J. etal. The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry 1992; 49: 630-636.
25. First M. B., Spitzer R. L., Gibbon M., Williams J. B. W., Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders-Patient Edition (SCID-II, Version 2.0). Washington, DC: American Psychiatric Press; 1995.
26. Spiegelhalter D. J., Best N. G., Carlin B. P., van der Linde A. Bayesian measures of model complexity and fit (with discussion). J R Stat Soc Ser B 2002; 64: 191-232.
27. Huntley Z., Maltezos S., Williams C., Morinan A., Hammon A., Ball D. etal. Rates of undiagnosed attention deficit hyperactivity disorder in London drug and alcohol detoxification units. BMC Psychiatry 2012; 12: 223.
28. Santucci K. Psychiatric disease and drug abuse. Curr Opin Pediatr 2012; 24: 233-237.
29. Molina B. S., Pelham W. E., Gnagy E. M., Thompson A. L., Marshal M. P. Attention-deficit/hyperactivity disorder risk for heavy drinking and alcohol use disorder is age specific. Alcohol Clin Exp Res 2007; 31: 643-654.
30. Lee S. S., Humphreys K. L., Flory K., Liu R., Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011; 31: 328-341.
31. Milberger S., Biederman J., Faraone S. V., Murphy J., Tsuang M. T. Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry 1995; 152: 1793-1799.
32. Biederman J., Petty C. R., Wilens T. E., Fraire M. G., Purcell C. A., Mick E. etal. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry 2008; 165: 107-115.
33. Christiansen H., Chen W., Oades R. D., Asherson P., Taylor E. A., Lasky-Su J. etal. Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorder. J Neural Transm 2008; 115: 163-175.
34. Skirrow C., Asherson P. Emotional lability, comorbidity and impairment in adults with attention-deficit hyperactivity disorder. J Affect Disord 2013; 147: 80-86.
35. Retz W., Stieglitz R. D., Corbisiero S., Retz-Junginger P., Rosler M. Emotional dysregulation in adult ADHD: what is the empirical evidence? Expert Rev Neurother 2012; 12: 1241-1251.
36. Faraone S., Biederman J., Mick E. The age dependent decline of attention-deficit/hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006; 36: 159-165.
37. Luyten P., Blatt S. J. Integrating theory-driven and empirically-derived models of personality development and psychopathology: a proposal for DSM V. Clin Psychol Rev 2011; 31: 52-68.
38. Kendler K. S., Aggen S. H., Knudsen G. P., Roysamb E., Neale M. C., Reichborn-Kjennerud T. The structure of genetic and environmental risk factors for syndromal and subsyndromal common DSM-IV axis I and all Axis II disorders. Am J Psychiatry 2011; 168: 29-39.
39. Roysamb E., Kendler K. S., Tambs K., Orstavik R. E., Neale M. C., Aggen S. H. etal. The joint structure of DSM-IV Axis I and Axis II disorders. J Abnorm Psychol 2011; 120: 198-209.
40. Farchione T. J., Fairholme C. P., Ellard K. K., Boisseau C. L., Thompson-Hollands J., Carl J. R. etal. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Ther 2012; 43: 666-678.
41. Mills K. L., Teesson M., Back S. E., Brady K. T., Baker A. L., Hopwood S. etal. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA 2012; 308: 690-699.
42. van den Bosch L. M., Verheul R., Schippers G. M., van den Brink W. Dialectical Behavior Therapy of borderline patients with and without substance use problems. Implementation and long-term effects. Addict Behav 2002; 27: 911-923.
43. Verheul R., Van Den Bosch L. M., Koeter M. W., De Ridder M. A., Stijnen T., Van Den Brink W. Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. Br J Psychiatry 2003; 182: 135-140.
44. van Emmerik-van Oortmerssen K., Vedel E., Koeter M. W., de Bruijn K., Dekker J. J., van den Brink W. etal. Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry 2013; 13: 132. doi: 10.1186/1471-244X-13-132.
45. Konstenius M., Jayaram-Lindstrom N., Beck O., Franck J. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend 2010; 108: 130-133.
46. Levin F. R., Evans S. M., Brooks D. J., Garawi F. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend 2007; 87: 20-29.
47. Levin F. R., Evans S. M., Brooks D. J., Kalbag A. S., Garawi F., Nunes E. V. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 2006; 81: 137-148.
48. Carpentier P. J., de Jong C. A., Dijkstra B. A., Verbrugge C. A., Krabbe P. F. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction 2005; 100: 1868-1874.
49. Riggs P. D., Winhusen T., Davies R. D., Leimberger J. D., Mikulich-Gilbertson S., Klein C. etal. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry 2011; 50: 903-914.